- •
Modifiable drug-specific exposures for nephrotoxicity are the duration of nephrotoxin treatment, cumulative or total daily dose of nephrotoxin, and pharmacokinetic and pharmacodynamic drug interactions.
- •
Acute kidney injury (AKI) detection strategies may mitigate further kidney injury, but they do little to prevent harm and have not used systematic creatinine surveillance for AKI in at-risk patients.
- •
The advent and wide dissemination of hospital-based electronic health records has led to automated
Drug-Induced Acute Kidney Injury: A Focus on Risk Assessment for Prevention
Section snippets
Key points
Epidemiology of drug-induced acute kidney injury
Critically ill patients receive twice the number of drugs as compared with non–critically ill patients, increasing the risk of developing significantly more adverse drug events, such as acute kidney injury (AKI).1, 2 Approximately 20% of the drugs prescribed in the intensive care unit (ICU) are considered nephrotoxic.3 Drugs are the third to fifth leading cause of AKI in this setting following sepsis and hypotension.4, 5, 6, 7 AKI occurs in 20% to 30% of critically ill patients, with drugs
Risk factors for drug-induced acute kidney injury
There are several susceptibilities and exposures that may contribute to AKI development as discussed in the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines.10, 21 Also a recent systematic review highlighted the risk factors for AKI in critically ill patients.9 The susceptibilities and exposures for AKI are listed in Table 1. Although these risks are for AKI, one assumes that they may apply to drug-induced AKI, although no specific comparison between risk factors of drug-induced AKI
Risk assessment for drug-induced acute kidney injury
Risk assessment for drug-induced AKI has predominantly been reactive in looking for AKI in patients who have been exposed to nephrotoxic medications. The advent and wide dissemination of hospital-based EHRs has led to automated AKI alerting systems, usually based on an increase in serum creatinine.30 EHR-based safety tools include kidney injury triggers, such as the Institute for Healthcare Improvement’s Global Trigger Tool,31 a recent tool using Acute Kidney Injury Network definition,32 or
Prevention of drug-induced acute kidney injury
Prevention is the best approach to averting harm associated with nephrotoxins. This most efficient approach to evaluating risk factors, as mentioned in the risk-assessment section (earlier), will require either manual or electronic surveillance. Early detection of patients at risk for AKI requires clinicians to shift their approach away from waiting for an increase in serum creatinine, as this biomarker lags by 24 to 48 hours behind initial kidney injury.47 Once high-risk patients are
Management of drug-induced acute kidney injury
One of the largest challenges in the management of drug-induced AKI is the identification of a drug-related cause. When trying to identify drug causes, we should review the patients’ entire medication list, including over-the-counter drugs and herbal products. An evaluation of suspected drugs includes consideration of the temporal sequence between the event and drug administration, objective evidence including drug concentrations when appropriate, prior knowledge of the event to support the
Future directions
Although the prevalence and impact of drug-induced AKI presents a serious health care burden, drug-induced AKI risk assessment remains generally relegated to broad demographic criteria; treatment consists of hydration and nephrotoxic medication avoidance. Recent efforts have commenced in 2 areas to personalize risk stratification and AKI detection: (1) assessment of genetic predisposition to specific nephrotoxic medications and (2) use of novel damage urinary biomarkers to identify AKI before
Summary
Drug-induced AKI is becoming recognized as a significant sequelae of care for hospitalized patients. Recent work to identify drug-induced AKI risk factors and develop systematic nephrotoxic medication exposure and AKI detection alerts and the association with the development of CKD has highlighted the enormous magnitude of the harm. It is hoped that current translational efforts to identify genetic polymorphisms that increase risk, or provide protection, to drug-induced AKI will allow us to
References (60)
- et al.
Drug-associated renal dysfunction
Crit Care Clin
(2006) - et al.
Spectrum of acute renal failure in the intensive care unit: the PICARD experience
Kidney Int
(2004) - et al.
Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months
J Pediatr
(2014) - et al.
Spectrum of acute kidney failure in the intensive care unit: the PICARD experience
Kidney Int
(2004) - et al.
The severity of acute kidney injury predicts progression to chronic kidney disease
Kidney Int
(2011) - et al.
trigger tool to identify adverse events in the intensive care unit
Jt Comm J Qual Patient Saf
(2006) - et al.
A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report
Am J Kidney Dis
(2010) - et al.
Daily serum creatinine monitoring promotes earlier detection of acute kidney injury in children and adolescents with cystic fibrosis
J Cyst Fibros
(2014) - et al.
Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial
Lancet
(2015) - et al.
Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results
J Crit Care
(2013)
Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units
Crit Care Med
Analysis of risk factors for adverse drug events in critically ill patients
Crit Care Med
Acute renal failure in intensive care units - causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure
Crit Care Med
Acute renal failure in critically ill patients: a multinational, multicenter study
JAMA
The epidemiology of acute renal failure in the world
Curr Opin Crit Care
Treatment-related acute renal failure in the elderly: a hospital-based prospective study
Nephrol Dial Transplant
Risk factors for development of acute kidney injury in critically ill patients: a systematic review and meta-analysis of observational studies
Crit Care Res Pract
Acute kidney injury in childhood: should we be worried about progression to CKD?
Pediatr Nephrol
Aki transition of care: a potential opportunity to detect and prevent CKD
Clin J Am Soc Nephrol
Yes, AKI truly leads to CKD
J Am Soc Nephrol
Acute kidney injury and chronic kidney disease as interconnected syndromes
N Engl J Med
Drug-induced acute interstitial nephritis
Nat Rev Nephrol
Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies
Crit Care Med
Mechanisms of drug-induced nephrotoxicity
Handb Exp Pharmacol
Drug-induced acute kidney injury
Curr Opin Crit Care
KDIGO clinical practice guideline for acute kidney injury
Kidney Int
Drug combinations and impaired renal function- the ‘triple whammy’
Br J Clin Pharmacol
Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French pharmacovigilance database
Fundam Clin Pharmacol
Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study
BMJ
QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions
Expert Opin Drug Saf
Cited by (65)
Editor's Choice – European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms
2024, European Journal of Vascular and Endovascular SurgeryClinical Characteristics and Outcomes of Drug-Induced Acute Kidney Injury Cases
2023, Kidney International ReportsDrug-related causes attributed to acute kidney injury and their documentation in intensive care patients
2023, Journal of Critical CareAdvances in laboratory detection of acute kidney injury
2022, Practical Laboratory MedicineKidneys in the Danger Zone
2022, Physician Assistant ClinicsCitation Excerpt :Monitor postrenal AKI to differentiate between decreasing urine output and urinary obstruction (may need a bladder scan).19 Drug-induced AKI accounts for up to 20% of AKI in the ICU.20 In one study, 3-year follow-up on the results of a quality improvement program showed a decrease of AKI by 64% in hospitalized children by drawing a SCr daily in children deemed high risk for AKI.21
Funding Sources: None.
Conflict of Interest: None.